Results 1 to 10 of about 1,100,659 (258)

Latest Research Hot Spots of Atopic Dermatitis Management Using Janus Kinase Inhibitor: A Bibliometric Analysis and Visualized Review. [PDF]

Clin Cosmet Investig Dermatol
Nukaly H, AlHuraish DS, Bakhamees BH, AlHemli HA, Alsaadoon MS, Alhejji RK, Alotaibi G, Alomran SA, AlHalees Z.   +8 more
europepmc   +1 more source

Preliminary Safety and Efficacy of Navitoclax Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis From the Multicenter, Open-Label, Phase 2 Study (REFINE). [PDF]

Hematol Oncol
Passamonti F, Foran JM, Tandra A, De Stefano V, Fox ML, Mattour A, McMullin MF, Perkins AC, Rodriguez-Macías G, Sibai HA, Polepally AR, Sun Y, Chopra AS, Harb JG, Qin Q, Potluri J, How J.   +16 more
europepmc   +1 more source

The Impact of Vehicle Occlusivity on Skin Delivery and Activity of a Janus Kinase Inhibitor: Comparison of Oil-Based Formulations. [PDF]

Pharmaceutics
Sarango-Granda P, Mohammadi-Meyabadi R, Braza AJ, Sosa L, Suñer-Carbó J, Mallandrich M, Calpena AC.   +6 more
europepmc   +1 more source

Refractory Lichen Amyloidosis Coexisting With Atopic Dermatitis Responsive to Sequential Janus Kinase Inhibitor Therapy: Upadacitinib Followed by Abrocitinib. [PDF]

Kaohsiung J Med Sci
Tsai YT, Lan J, Lin SH.
europepmc   +1 more source

Correction to: Bone Mineral Density During Treatment with The Janus Kinase Inhibitor Baricitinib in Patients with Rheumatoid Arthritis: A Monocentric Observational Study. [PDF]

Calcif Tissue Int
Schulz N, Asendorf T, van Wijnen P, Wilhelmi T, Müller-Ladner U, Lange U, Klemm P.   +6 more
europepmc   +1 more source

Incidental treatment of granulomatosis with polyangiitis with a Janus Kinase inhibitor in a patient undergoing alopecia treatment. [PDF]

JAAD Case Rep
Mendez D, Xiang L, Bergfeld W.
europepmc   +1 more source

Ruxolitinib cream for the treatment of granuloma annulare

JAAD Case Reports
Austin J. Piontkowski, BS, Nancy Wei, MD, Aisha Mumtaz, MD, Nicholas Gulati, MD, PhD   +3 more
doaj   +1 more source

Treatment of Hailey-Hailey disease with the Janus kinase inhibitor abrocitinib: A case report. [PDF]

SAGE Open Med Case Rep
Gunyon M, Udupa M, Mahmood F, Foulkes WD, Pehr K, Netchiporouk E.   +5 more
europepmc   +1 more source

Efficacy and safety of momelotinib in Janus kinase inhibitor-experienced Asian patients with myelofibrosis and anemia. [PDF]

Int J Hematol
Yoon SS, Chen CC, Lee SE, Chang H, Cheong JW, Hou HA, Lee WS, Lim SN, Moon JH, Ong KH, Dai Y, Liu C, Kawashima J, Goh YT.   +13 more
europepmc   +1 more source